History
  • No items yet
midpage
Thomas Whitaker v. Bryan Collier
862 F.3d 490
5th Cir.
2017
Read the full case

Background

  • Whitaker and Williams, both sentenced to death in Texas, sued under 42 U.S.C. § 1983 challenging Texas’s execution protocol (notably the switch to compounded pentobarbital) on Eighth, First, Sixth, and Fourteenth Amendment grounds.
  • Plaintiffs filed initially in 2013 after Texas’s 2013 change from manufactured to compounded pentobarbital; prior appeals produced remand allowing challenge to the existing protocol.
  • Second amended complaint alleged (1) no-notice provision for protocol changes; (2) no right to counsel around execution; (3) inadequate testing/BUD and safeguards for compounded pentobarbital; (4) concealment/refusal to disclose protocol details.
  • Defendants (TDCJ) moved to dismiss under Rule 12(b)(6); district court permitted limited discovery and Texas stipulated to additional drug testing, then dismissed all claims as time‑barred or insufficiently pleaded.
  • Fifth Circuit majority: affirmed dismissal — held many claims were time‑barred because only “substantial” protocol changes reset accrual and the 2013 switch to compounded pentobarbital was not substantial; alternatively, plaintiffs failed to plead an Eighth Amendment method‑of‑execution claim under Glossip/Baze standards.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether plaintiffs’ claims are time‑barred (accrual date) Accrual occurred when Texas switched to compounded pentobarbital in Sept. 2013 (or continuing injury) Limitations accrued when direct review ended unless a substantial protocol change occurred; protocol not a continuing tort Claims based on aspects unchanged since 2008 are time‑barred; switch to compounded pentobarbital is not a substantial change so does not reset accrual for many claims
Whether using compounded pentobarbital and limited testing state a method‑of‑execution (Eighth) claim Single pre‑delivery test and extended BUD create substantial, imminent risk of severe pain; alternatives (FDA drugs) are feasible Allegations are speculative; no factual showing of a substantial, imminent risk nor a pleaded feasible alternative that significantly reduces risk Pleadings are too speculative under Glossip/Baze; failure to allege substantial risk or adequate alternative — dismissal affirmed
Whether lack of notice/disclosure or secrecy violates due process or right of access to courts Secrecy and no-notice prevent meaningful challenge and access to courts; implicates due process and First Amendment access Secrecy does not itself create an Eighth Amendment risk or a cognizable liberty interest; access claim is speculative without a viable underlying Eighth claim No liberty interest shown; disclosure/notice claims fail; access‑to‑courts claim fails because underlying claims are not plausibly pleaded
Whether right to counsel at execution (First/Sixth/Eighth) is implicated Plaintiffs assert need for counsel during events leading up to/during execution to protect constitutional rights Sixth Amendment counsel right ends with first appeal of right; no pleaded substantial risk from lack of counsel; speculative “botched execution” theory Sixth Amendment claim fails; access‑to‑counsel and related claims are not pleaded to meet Eighth Amendment method‑of‑execution standards

Key Cases Cited

  • Walker v. Epps, 550 F.3d 407 (5th Cir.) (statute‑of‑limitations accrual rule for § 1983 method‑of‑execution claims)
  • Glossip v. Gross, 135 S. Ct. 2726 (U.S.) (Eighth Amendment method‑of‑execution standard: substantial risk + feasible alternative)
  • Baze v. Rees, 553 U.S. 35 (U.S.) (framework for Eighth Amendment lethal‑injection claims)
  • Hill v. McDonough, 547 U.S. 573 (U.S.) (equitable limits on stays for method‑of‑execution suits; caution against piecemeal litigation)
  • Gissendaner v. Comm’r, Ga. Dep’t of Corr., 779 F.3d 1275 (11th Cir.) (substantial‑change rule: accrual resets only for substantial protocol changes and only as to changed aspect)
  • Zink v. Lombardi, 783 F.3d 1089 (8th Cir.) (compounded pentobarbital allegations too speculative at motion‑to‑dismiss)
  • Wood v. Collier, 836 F.3d 534 (5th Cir.) (denial of stay where retesting not constitutionally required; posture addressing similar compounded‑drug claims)
  • Sepulvado v. Jindal, 729 F.3d 413 (5th Cir.) (no cognizable due‑process liberty interest from protocol‑disclosure claims)
  • Ashcroft v. Iqbal, 556 U.S. 662 (U.S.) (pleading standard: conclusory allegations insufficient)
Read the full case

Case Details

Case Name: Thomas Whitaker v. Bryan Collier
Court Name: Court of Appeals for the Fifth Circuit
Date Published: Jul 7, 2017
Citation: 862 F.3d 490
Docket Number: 16-20364
Court Abbreviation: 5th Cir.